North America Custom Antibody Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The North America custom antibody services market is projected to grow significantly, reaching approximately US$ 577.76 million by 2031, up from US$ 287.49 million in 2023, with an estimated compound annual growth rate (CAGR) of 9.1% from 2023 to 2031.

Executive Summary and Market Analysis

The custom antibody services market in North America is divided into three main regions: the United States, Canada, and Mexico. Several factors are driving the growth of this market, including the increasing adoption of advanced technologies, rising investments in drug discovery and development, strong government support for clinical research, and a surge in research activities in clinical diagnostics. Additionally, collaborations between government bodies and market players are promoting the use of custom antibodies in clinical diagnostics. The growing number of cancer and genomic research initiatives in the US and Canada, along with a focus on developing antibody-based therapeutics, are also contributing to market expansion. The demand for high-quality research tools to ensure data reproducibility further supports the growth of the custom antibody services market in North America.

Market Segmentation Analysis

The North America custom antibody services market can be segmented based on product type, service type, application, disease indication, source, and end user:

Product Type: The market is categorized into monoclonal, polyclonal, hybridoma, recombinant antibodies, and others. In 2023, monoclonal antibodies held the largest market share.
Service Type: This segment includes antibody discovery and development, antibody production services, and others, with antibody discovery and development leading in market share in 2023.
Application: The applications include immunohistochemistry, western blotting & immunoprecipitation (IP), ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. ELISA was the most significant application in 2023.
Disease Indication: The market is segmented into oncology, infectious diseases, immunology, cardiovascular diseases, and others, with oncology being the largest segment in 2023.
Source: This includes chicken, rabbits, rats, guinea pigs, and mouse or humanized mice, with the latter holding the largest share in 2023. This segment is further divided into various platforms for monoclonal antibodies and other technologies.
End User: The end users include the life sciences industry, pharmaceutical and biotech companies, academic and research institutes, and contract research organizations, with the life sciences industry leading in market share in 2023.

Market Outlook

The FDA plays a crucial role in approving biosimilar products, which enhances patient care by providing more medication options at potentially lower costs. Recent approvals of biosimilars, such as Alymsys and Cimerli, have been significant in expanding treatment options. The increasing number of biosimilars approved by the FDA is expected to drive the growth of the custom antibody services market, as they can lower treatment costs and improve access to biologic therapies.

Country Insights

The North American custom antibody services market is primarily driven by the US, which accounted for the largest share in 2023. The rising incidence of infectious, chronic, and autoimmune diseases in the US is increasing the demand for custom antibody services. Cancer remains a leading cause of death, with over 1.9 million new cases diagnosed in 2022, and projections suggest around 2.0 million new diagnoses in 2024. Custom antibodies are essential in cancer treatment for detecting tumor-specific antigens and monitoring patient progress. The US market benefits from increased R&D efforts and the growing use of custom antibodies across various research fields, including oncology and immunology.

Company Profiles

Key players in the custom antibody services market include Thermo Fisher Scientific Inc., Sino Biological Inc., GenScript Biotech Corporation, Biochain Incorporated, R&D Systems, Inc., Kaneka Eurogentec S.A., Fortis Life Sciences, Precision Antibody, Biocytogen Pharmaceuticals, Abgenex, Creative Biolabs, Agilent Technologies, Bioklone, and Scantibodies Laboratory, Inc. These companies are employing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their customers.

Product Code: BMIRE00032161

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Custom Antibody Services Market Landscape

4.1 Overview
4.2 PEST Analysis

5. North America Custom Antibody Services Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Chronic Diseases
- 5.1.2 Rising Approvals of Biosimilars
5.2 Market Restraints
- 5.2.1 High Costs and Complexities Associated with Antibody Production Using Transgenic Animals
5.3 Market Opportunities
- 5.3.1 Rise in Government Research and Development Activities in Emerging and Developed Economies
5.4 Future Trends
- 5.4.1 Technological Advancements Using Recombinant Antibodies
5.5 Impact of Drivers and Restraints:

6. Custom Antibody Services Market - North America Analysis

6.1 North America Custom Antibody Services Market Revenue (US$ Million), 2021-2031
6.2 North America Custom Antibody Services Market Forecast Analysis

7. North America Custom Antibody Services Market Analysis - by End User

7.1 Life Science Industry
- 7.1.1 Overview
- 7.1.2 Life Science Industry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Pharmaceutical and Biotech Companies
- 7.2.1 Overview
- 7.2.2 Pharmaceutical and Biotech Companies: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Academic and Research Institutes
- 7.3.1 Overview
- 7.3.2 Academic and Research Institutes: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Contract Research Organizations
- 7.4.1 Overview
- 7.4.2 Contract Research Organizations: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Custom Antibody Services Market Analysis - by Disease Indication

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Infectious Diseases
- 8.2.1 Overview
- 8.2.2 Infectious Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Immunology: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Cardiovascular Diseases
- 8.4.1 Overview
- 8.4.2 Cardiovascular Diseases: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Custom Antibody Services Market Analysis - by Source

9.1 Chicken
- 9.1.1 Overview
- 9.1.2 Chicken: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Rabbits
- 9.2.1 Overview
- 9.2.2 Rabbits: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Rats
- 9.3.1 Overview
- 9.3.2 Rats: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Guinea Pigs
- 9.4.1 Overview
- 9.4.2 Guinea Pigs: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.5 Mouse or Humanized Mice
- 9.5.1 Overview
- 9.5.2 Mouse or Humanized Mice: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Custom Antibody Services Market Analysis - by Mouse or Humanized Mice

10.1 Monoclonal Antibody Platform
- 10.1.1 Overview
- 10.1.2 Monoclonal Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2 BsAb Discovery Platform
- 10.2.1 Overview
- 10.2.2 BsAb Discovery Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Bispecific ADC Platform
- 10.3.1 Overview
- 10.3.2 Bispecific ADC Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4 TCR-Mimic Antibody Platform
- 10.4.1 Overview
- 10.4.2 TCR-Mimic Antibody Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5 Anti-GPCR Antibody Technology Platform
- 10.5.1 Overview
- 10.5.2 Anti-GPCR Antibody Technology Platform: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. North America Custom Antibody Services Market Analysis - by Application

11.1 Immunohistochemistry (IHC)
- 11.1.1 Overview
- 11.1.2 Immunohistochemistry (IHC): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.2 Western Blot and IP
- 11.2.1 Overview
- 11.2.2 Western Blot and IP: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.3 ELISA
- 11.3.1 Overview
- 11.3.2 ELISA: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.4 Fluorescence-activated cell sorting (FACS)
- 11.4.1 Overview
- 11.4.2 Fluorescence-activated cell sorting (FACS): North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.5 Mass Spectrometry
- 11.5.1 Overview
- 11.5.2 Mass Spectrometry: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
11.6 Others
- 11.6.1 Overview
- 11.6.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. North America Custom Antibody Services Market Analysis - by Service Type

12.1 Antibody Discovery and Development
- 12.1.1 Overview
- 12.1.2 Antibody Discovery and Development: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2 Antibody Production Services
- 12.2.1 Overview
- 12.2.2 Antibody Production Services: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3 Others
- 12.3.1 Overview
- 12.3.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

13. North America Custom Antibody Services Market Analysis - by Product Type

13.1 Monoclonal
- 13.1.1 Overview
- 13.1.2 Monoclonal: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.2 Polyclonal hybridoma
- 13.2.1 Overview
- 13.2.2 Polyclonal hybridoma: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.3 Recombinant antibody
- 13.3.1 Overview
- 13.3.2 Recombinant antibody: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
13.4 Others
- 13.4.1 Overview
- 13.4.2 Others: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

14. North America Custom Antibody Services Market - Country Analysis

14.1 North America
- 14.1.1 North America Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.1 North America Custom Antibody Services Market - Revenue and Forecast Analysis - by Country
  - 14.1.1.2 United States: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.2.1 United States: North America Custom Antibody Services Market Share - by End User
    - 14.1.1.2.2 United States: North America Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.2.3 United States: North America Custom Antibody Services Market Share - by Source
    - 14.1.1.2.4 United States: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.2.5 United States: North America Custom Antibody Services Market Share - by Application
    - 14.1.1.2.6 United States: North America Custom Antibody Services Market Share - by Service Type
    - 14.1.1.2.7 United States: North America Custom Antibody Services Market Share - by Product Type
  - 14.1.1.3 Canada: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.3.1 Canada: North America Custom Antibody Services Market Share - by End User
    - 14.1.1.3.2 Canada: North America Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.3.3 Canada: North America Custom Antibody Services Market Share - by Source
    - 14.1.1.3.4 Canada: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.3.5 Canada: North America Custom Antibody Services Market Share - by Application
    - 14.1.1.3.6 Canada: North America Custom Antibody Services Market Share - by Service Type
    - 14.1.1.3.7 Canada: North America Custom Antibody Services Market Share - by Product Type
  - 14.1.1.4 Mexico: North America Custom Antibody Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 14.1.1.4.1 Mexico: North America Custom Antibody Services Market Share - by End User
    - 14.1.1.4.2 Mexico: North America Custom Antibody Services Market Share - by Disease Indication
    - 14.1.1.4.3 Mexico: North America Custom Antibody Services Market Share - by Source
    - 14.1.1.4.4 Mexico: North America Custom Antibody Services Market Share - by Mouse Or Humanized Mice
    - 14.1.1.4.5 Mexico: North America Custom Antibody Services Market Share - by Application
    - 14.1.1.4.6 Mexico: North America Custom Antibody Services Market Share - by Service Type
    - 14.1.1.4.7 Mexico: North America Custom Antibody Services Market Share - by Product Type

15. Custom Antibody Services Market - Industry Landscape

15.1 Overview
15.2 Growth Strategies in Custom Antibody Services Market
15.3 Organic Growth Strategies
- 15.3.1 Overview
15.4 Inorganic Growth Strategies
- 15.4.1 Overview

16. Company Profiles

16.1 Thermo Fisher Scientific Inc
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 Sino Biological Inc.
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 GenScript Biotech Corporation
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Biochain Incorporated
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 R&D Systems, Inc
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 Kaneka Eurogentec S.A.
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Fortis Life Sciences
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Precision Antibody (A&G Pharmaceutical, Inc.)
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Biocytogen Pharmaceuticals Beijing Co Ltd
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Abgenex
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments
16.11 Creative Biolabs Inc
- 16.11.1 Key Facts
- 16.11.2 Business Description
- 16.11.3 Products and Services
- 16.11.4 Financial Overview
- 16.11.5 SWOT Analysis
- 16.11.6 Key Developments
16.12 Agilent Technologies Inc
- 16.12.1 Key Facts
- 16.12.2 Business Description
- 16.12.3 Products and Services
- 16.12.4 Financial Overview
- 16.12.5 SWOT Analysis
- 16.12.6 Key Developments
16.13 Bioklone
- 16.13.1 Key Facts
- 16.13.2 Business Description
- 16.13.3 Products and Services
- 16.13.4 Financial Overview
- 16.13.5 SWOT Analysis
- 16.13.6 Key Developments
16.14 Scantibodies Laboratory, Inc.
- 16.14.1 Key Facts
- 16.14.2 Business Description
- 16.14.3 Products and Services
- 16.14.4 Financial Overview
- 16.14.5 SWOT Analysis
- 16.14.6 Key Developments

17. Appendix

17.1 About The Insight Partners
17.2 Glossary of Terms